
    
      The purpose of this study is to investigate if ONO-4053 will impact allergic rhinitis
      symptoms in subjects with seasonal allergic rhinitis when they are exposed to pollen
      administered at a fixed rate in an inhalation exposure chamber compared to the standard
      treatment Cetirizine 10mg under the same conditions.
    
  